152 related articles for article (PubMed ID: 12447630)
1. The prevalence and significance of positive antinuclear antibodies in patients with fibromyalgia syndrome: 2-4 years' follow-up.
Al-Allaf AW; Ottewell L; Pullar T
Clin Rheumatol; 2002 Nov; 21(6):472-7. PubMed ID: 12447630
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibodies and connective tissue disease features in fibromyalgia syndrome: a controlled study.
Yunus MB; Hussey FX; Aldag JC
J Rheumatol; 1993 Sep; 20(9):1557-60. PubMed ID: 8164214
[TBL] [Abstract][Full Text] [Related]
3. Outcome of positive antinuclear antibodies in individuals without connective tissue disease.
Myckatyn SO; Russell AS
J Rheumatol; 2003 Apr; 30(4):736-9. PubMed ID: 12672192
[TBL] [Abstract][Full Text] [Related]
4. Women's health after plastic surgery.
Englert H; Joyner E; McGill N; Chambers P; Horner D; Hunt C; Makaroff J; O'Connor H; Russell N; March L
Intern Med J; 2001 Mar; 31(2):77-89. PubMed ID: 11480483
[TBL] [Abstract][Full Text] [Related]
5. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease.
Ravelli A; Felici E; Magni-Manzoni S; Pistorio A; Novarini C; Bozzola E; Viola S; Martini A
Arthritis Rheum; 2005 Mar; 52(3):826-32. PubMed ID: 15751057
[TBL] [Abstract][Full Text] [Related]
6. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physicians.
Suarez-Almazor ME; Gonzalez-Lopez L; Gamez-Nava JI; Belseck E; Kendall CJ; Davis P
J Rheumatol; 1998 Oct; 25(10):1980-5. PubMed ID: 9779854
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria.
Shin JI; Kim KH; Chun JK; Lee TJ; Kim KJ; Kim HS; Kim DS
Scand J Rheumatol; 2008; 37(5):348-51. PubMed ID: 18666025
[TBL] [Abstract][Full Text] [Related]
9. A prospective evaluation of 118 patients with the fibromyalgia syndrome: prevalence of Raynaud's phenomenon, sicca symptoms, ANA, low complement, and Ig deposition at the dermal-epidermal junction.
Dinerman H; Goldenberg DL; Felson DT
J Rheumatol; 1986 Apr; 13(2):368-73. PubMed ID: 3487650
[TBL] [Abstract][Full Text] [Related]
10. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance.
Imazio M; Brucato A; Doria A; Brambilla G; Ghirardello A; Romito A; Natale G; Palmieri G; Trinchero R; Adler Y
Int J Cardiol; 2009 Aug; 136(3):289-93. PubMed ID: 18674829
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
Tzaneva S; Volc-Platzer B; Kittler H; Hönigsmann H; Tanew A
Br J Dermatol; 2008 May; 158(5):1050-4. PubMed ID: 18341657
[TBL] [Abstract][Full Text] [Related]
12. Is high titre ANA specific for connective tissue disease?
Vaile JH; Dyke L; Kherani R; Johnston C; Higgins T; Russell AS
Clin Exp Rheumatol; 2000; 18(4):433-8. PubMed ID: 10949716
[TBL] [Abstract][Full Text] [Related]
13. Fibromyalgia in Iraqi patients with Behcet's disease.
Al-Izzi MK; Jabber AS
J Med Liban; 2004; 52(2):86-90. PubMed ID: 15884687
[TBL] [Abstract][Full Text] [Related]
14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
15. Increased titres of anti-nuclear antibodies do not predict the development of associated disease in the absence of initial suggestive signs and symptoms.
Dinser R; Braun A; Jendro MC; Engel A
Scand J Rheumatol; 2007; 36(6):448-51. PubMed ID: 18092266
[TBL] [Abstract][Full Text] [Related]
16. Antinuclear antibodies appearing during PUVA therapy.
Bruze M; Ljunggren B
Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
[TBL] [Abstract][Full Text] [Related]
17. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies are not increased in the early phase of Borrelia infection.
Spiewak R; Stojek NM; Chmielewska-Badora J
Ann Agric Environ Med; 2004; 11(1):145-8. PubMed ID: 15236512
[TBL] [Abstract][Full Text] [Related]
19. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
20. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis.
De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G
Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
